课题基金 / 基金详情

The Role of Type III Interferon in Innate Immunity to Respiratory Virus Infection

The Role of Type III Interferon in Innate Immunity to Respiratory Virus Infection
III 型干扰素在呼吸道病毒感染先天免疫中的作用
批准号:
7932906
负责人:
Joan E. Durbin
金额:
$80.99万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-17 至 2012-08-31

项目摘要

项目成果

Joan E. Durbin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Type III, or-lambda, interferons (IFN) make up a newly discovered family of cytokines which, like the type I IFNs (alpha/beta), are induced by virus infection. IFN-lambda's signaling, through a unique receptor, leads to formation of the same interferon stimulated gene factor 3 (ISGF3) transcription complex activated by IFN- alpah/beta, and therefore has very similar effects. The primary difference noted so far between the type I and type III IFNs is the very limited distribution of the IFN-lambda receptor, in contrast to the IFN-alpha/beta receptor which is ubiquitously expressed. As the IFN-lambda receptor is expressed primarily by epithelial cells and dendritic cells, it has been suggested that this cytokine may be of particular importance in protection from mucosal infections by viral pathogens. In a mouse model of influenza A virus infection we have made the novel observation that IFN-lambda is the primary IFN induced by intranasal infection, and have found that this induction can occur even in the absence of IFN-alpha/beta signaling. It is our hypothesis that this alternatively regulated family of anti-viral IFNs has a unique role in protecting the host from respiratory virus infection. We will test this hypothesis using gene-targeted mice and primary airway epithelial cell cultures to investigate the ways in which type I and type III IFNs have overlapping versus distinctive functions in protection of respiratory tract. We propose the following aims: 1) Demonstrate the requirement for IFN signaling via ISGF3, and investigate the relative importance of type I and type III IFNs for effective innate immune protection against influenza virus. 2) Identify the source(s) of IFN-lambda in influenza virus infection, as well the responding cell types. 3) Characterize production of, and responsiveness to, type I and type III IFNs by polarized airway epithelial cells. 4) Determine the role of IFN-lambda in pDC maturation and function during influenza virus infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUPPLEMENT TO: A Novel approach to RSV vaccination
  • 批准号:
    8846767
  • 项目类别:
  • 资助金额:
    $52.55万
  • 财政年份:
    2013
  • 负责人:
    Joan E. Durbin
  • 依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
  • 批准号:
    8606404
  • 项目类别:
  • 资助金额:
    $118.56万
  • 财政年份:
    2013
  • 负责人:
    Joan E. Durbin
  • 依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
  • 批准号:
    8704177
  • 项目类别:
  • 资助金额:
    $103.69万
  • 财政年份:
    2013
  • 负责人:
    Joan E. Durbin
  • 依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
  • 批准号:
    8784187
  • 项目类别:
  • 资助金额:
    $118.59万
  • 财政年份:
    2013
  • 负责人:
    Joan E. Durbin
  • 依托单位:
国内基金
海外基金
TPLATE Complex通过胞吞调控CLV3-CLAVATA多肽信号模块维持干细胞稳态的分子机制研究
二甲双胍对于模型蛋白、γ-secretase、Complex I自由能曲面的影响
高脂饮食损伤巨噬细胞ndufs4表达激活Complex I/mROS/HIF-1通路参与溃疡性结肠炎研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    赵锐
  • 依托单位:
线粒体参与呼吸中枢pre-Bötzinger complex呼吸可塑性调控的机制研究